Cancer Control Trials

E1Z11: A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)Aims: The purpose of this study is to find out what effects, good an/or bad , that anastrozole has on patients and whether the genes and blood can help explain how the study drug, anastrozole affects the body. Specifically, many women who take anastrozole or one of the other aromatase inbibitors (letrozole or exemestane) during treatment for breast cancer report muscle and joint aches, however, the reason that lead to these symptoms are not known. These symptoms have been designated aramoatase inhibitor-associated musculoskeletal symptom. Diagnosis: Breast CancerPrincipal Investigator: Douglas Merkel, MD IRB Approval Number: EH13-444Sponsor: ECOGContact: Interested patients should contact research coordinator Nancy Haefling at 847.657.5957Open to Enrollment: Yes

Home -Based Symptom management via Reflexology for Breast Cancer PatientsAims: The purpose of this research is to learn if a complementary therapy, called Reflexology (a specialized foot massage), provided by a friend or family member will help patients feel better physically and/or emotionally during cancer therapy. The study has the potential of leading to an enhanced system of care for breast cancer through the integration of conventional scientifically-based complementary therapies. It also focuses on advanced disease that is currently under investigation in terms of supportive care services. Diagnosis: Breast CancerPrincipal Investigator: Elaine Wade, MD IRB Approval Number: EH14-025Sponsor: Michigan State University and National Cancer InstituteContact: Interested patients should contact research coordinator Nancy Haefling at 847.657.5957Open to Enrollment: Yes

UC13-0138: Developing a Financial Toxicity Patient-reported Outcome (PRO) Measure in Patients with Advanced Cancer and Assessing their Willingness to Discuss CostsAims: The purpose of this research is to develop a survey that will measure the effect of cancer and cancer treatment on a patient's financial well-being and quality of life. We think that financial burden might affect well being.Diagnosis: Advanced CancerPrincipal Investigator: Bruce Brockstein, M.D.IRB Approval Number: EH13-322Sponsor: University of ChicagoContact: Interested patients should contact research coordinator Nancy Haefling at 847.657.5957Open to Enrollment: Yes